Abstract: Provided is a kit comprising a first pharmaceutical composition comprising a first cannabinoid and optionally a first terpene and/or a first additive; and a second pharmaceutical composition comprising at least one selected from the group consisting of a second cannabinoid, a second terpene, a second additive and combinations thereof, and uses thereof in the treatment of pelvic pain arising from the female reproductive system. Further provided are methods of treatment of pelvic pain arising from a female reproductive system during a menstrual cycle, the method comprising administering during a first fraction of said menstrual cycle a first pharmaceutical composition comprising a first cannabinoid and optionally a first terpene and/or a first additive, and administering during a second fraction of said menstrual cycle a second pharmaceutical composition comprising at least one selected from the group consisting of a second cannabinoid, a second terpene, a second additive and combinations thereof.

Abstract: A terpene-enriched cannabinoid therapeutic product and methods for use thereof in treating conditions and/or symptoms associated with autism and/or autism spectrum disorder, the product including at least one cannabinoid, at least one primary terpene, and optionally at least three secondary terpenes, where the product has a therapeutic effect in treating conditions and/or symptoms associated with autism and/or autism spectrum disorder, and where said therapeutic effect is an enhanced therapeutic effect compared with that of a composition including the same cannabinoids amounts and one fifth the amount of said at least one primary terpene.